The TREAT-NMD Clinical Trials Coordination Centre (CTCC) has been set up to work with pharmaceutical companies to facilitate every aspect of the trials process in Europe.

We have already successfully implemented the Care and Trials Site Registry and the Regulatory Affairs Database and have conducted pre-feasiblity studies that have given us valuable information about suitable centres and the patient cohorts available. All this vital groundwork means we can dramatically speed up the trial preparation process for companies wishing to conduct trials in this area.

The CTCC is associated with the Neuropediatric Department of the University Children's Hospital of Freiburg and the Clinical Trial Centre of the University of Freiburg. The Clinical Trial Centre can provide full CRO services and already has extensive experience in the planning, conduct and analysis of multinational clinical trials for the pharmaceutical and medical device industry and scientific investigator initiated trials.

Prof. Rudolf Korinthenberg, MD is head of the Department of Neuropediatrics and Muscular Disorders at Children’s Hospital, University Hospital Freiburg. He received his pediatric and neuropediatric training at University Hospital Münster/Westfalia and holds his actual position since 1990. He has published on a broad range of topics in child neurology, and during the last 18 years has concentrated on clinical scientific work in neuromuscular disorders. He has conducted several German multicentric trials in NMD as principal investigator, and he is head of the Trials Organisation Center of MD-Net and The Clinical Trials Coordination Center of TREAT-NMD.

Dr. Jan Kirschner is  coordinator of the Clinical Trial Coordination Centre (CTCC) based in Freiburg, Germany. Jan is joint coordinator of the German MD-NET since 2008 and was responsible for the coordination of a large multi-centre, placebo-controlled MD-NET trial in Duchenne muscular dystrophy. Jan has a long-standing interest in the diagnosis and treatment of myopathies and muscular dystrophies in children and is head of the neuromuscular laboratory at Freiburg University. Current areas of research activities include the pathogenesis of muscular dystrophies and clinical  trials in neurmuscular disorders. With the CTCC team Jan has established the TREAT-NMD trial site registry and works to improve trial readiness in the field of neuromuscular disorders.

Kathrin Gramsch has a Bachelor of Science Degree in Health Management and is a Certified Project Management Associate. Before that she worked as a physiotherapist for over 13 years in the paediatric neuromuscular field. She joined the TREAT-NMD Clinical Trials Coordination Center in December 2008, where she is responsible for the industry request to the Care and Trial Site Registry, Reporting and Budget control, the training workshop organizations and will be also managing the newly funded CARE-NMD project.

Sebastian Geismann is a lawyer who specialises in European und public international law. He has been working at the Clinical Trials Center Freiburg since May 2007. He is engaged in Regulatory Affairs concerning clinical trials. Within the TREAT-NMD Network he is responsible for implementing and updating the Regulatory Affairs Database. Furthermore, he is involved in the legal consulting of TREAT-NMD members who are planning multi-national studies.

Ursula Wein is a pediatric nurse and a qualified study nurse. For the last 6 years, she worked as a study nurse for the PAED-Module Freiburg. Since October 2008 she works at the TREAT-NMD Clinical Trial Coordination Center in close collaboration with the Neuropaediatric Department of the University Childrens Hospital Freiburg. Her duties include coordinating and performing clinical trials.

Adrian Tassoni is an IT-Specialist and Junior IT-Consultant. He is involved in the conception and implementation of clinical trial related software at the Clinical Trials Centre of the University Medical Center Freiburg . In the context of TREAT-NMD he is responsible for concepting, implementing and maintaining the Regulatory Affairs Database and other applications such as the Clinical Trials Centre Database, as well as performing general technical support for the CTCC members.